跳至主要内容
临床试验/NCT04876846
NCT04876846已完成不适用

Trans-abdominal Fetal Pulse Oximetry; Tissue Light Scattering and Signal Integrity

Raydiant Oximetry, Inc.2 个研究点 分布在 1 个国家目标入组 9 人开始时间: 2021年4月24日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
9
试验地点
2
主要终点
Fetal Signal

研究概览

简要总结

The overall purpose of this study is to evaluate maternal-fetal tissue light scattering properties. The objectives of the study are: (i) integrate established mathematical principles of oxygen saturation to model with increasing accuracy the "body in a body" problem of fetus in mother; similar to existing pulse oximeters, the calculations will be integrated into software in the final commercial product; (ii) obtain human measurements against which both computational models and animal data can be compared.

详细描述

This is a prospective, observational, non-significant risk study. The study involves using non-invasive devices that measure fetal depth and tissue light scattering on the maternal abdomen. Ultrasound assessment will be performed, and multiple images taken at various locations on the abdomen. All images will be captured with minimal probe pressure applied to allow accurate ascertainment of depth. Images will be anonymized, and all study data will be coded with a unique identifier. Key maternal descriptive statistics will be recorded from the medical record including BMI, height, weight (kg), parity, age and gestational age.

The ISS device is a customized commercial frequency domain oximeter (Imagent, ISS Inc.; http://www.iss.com/biomedical/instruments/imagent.html) with multiple laser sources and multiple detectors. This instrument is safe, uses non-ionizing radiation.

The Raydiant Lumerah device is a non-invasive fetal pulse oximeter that measures fetal arterial oxygen saturation using safe, non-invasive, transabdominal near-infrared spectroscopy. The Lumerah device will be positioned on the maternal abdomen of women volunteers in the late 3rd trimester.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Device Feasibility
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Women with singleton, healthy pregnancy at gestational age ≥ 36 weeks
  • Age > 18 years
  • Willing to come in for testing outside of routine business hours (including Saturdays)

排除标准

  • Multiple gestation (twins, triplets)
  • Presentation other than vertex or breech
  • < 36 weeks of gestation

结局指标

主要结局

Fetal Signal

时间窗: After 36 weeks of pregnancy

Correlation of the fetal doppler signal with the ROSS device optional fetal signal.

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验